Focal Therapy for Localized Prostate Cancer
Recruiting now
Conditions studied: Prostate Cancer
In brief
This prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy. The goal of which is to improve patient care.
Key facts
- Study ID
- NCT06270043
- Run by
- University of California, San Diego
- People needed
- 500
- Starts
- 2024-02-01
- Expected to finish
- 2034-02-01
- Last updated by the study team
- 2024-02-26
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
- PSA ≤ 20
- Ability to complete informed consent form
You may not qualify if…
- Contraindication to follow-up multi parametric MRI or prostate biopsy
- Unable to tolerate general or regional anesthesia
Where it is running
- University of California, San Diego — La Jolla, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.